Here, we selected tumor immunity-related biological markers, including CD8, FOXP3, and CD163, which, respectively, represented CD8+ T cells, FOXP3+ Treg cells, and CD163+ M2 macrophages to analyze different advanced GC types. The gene discussed is FOXP3; the disease is neoplasm.